Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00551720 · ClinicalTrials.gov registry record · Phase 3
Motivation and Patch Treatment for HIV-positive Smokers
A Phase 3 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 3
- Development phase
- 444
- Enrollment target
NCT00551720 is a Phase 3 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 444 participants.
The verdict
NCT00551720, a Phase 3 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 444 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and evaluate a brief, clinic-based smoking cessation treatment for an HIV+ population. We compared two treatments, a brief advice and follow-up plus nicotine patch treatment(Standard Care; SC) and brief advice and follow-up, nicotine patch, with the addition of a tailored motivational intervention and behavioral skills counseling for smoking cessation (Motivationally-Enhanced; ME), in a randomized controlled trial. We hypothesized that those HIV+ participants receiving the ME will demonstrate greater biochemically verified smoking abstinence rates at 6-month follow-up than those receiving the SC control treatment. All study participants were offered use of the nicotine patch.
Interventions
- BEHAVIORAL Standard Care
- BEHAVIORAL Motivational Enhancement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 444 participants |
| Start Date | 1999-01 |
| Est. Completion | 2004-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00551720
The ClinicalTrials.gov registry entry for NCT00551720 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 444 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Care is the first listed.
NCT00551720 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00551720 about?
NCT00551720 is a clinical study titled "Motivation and Patch Treatment for HIV-positive Smokers". The purpose of this study is to develop and evaluate a brief, clinic-based smoking cessation treatment for an HIV+ population. We compared two treatments, a brief advice and follow-up plus nicotine patch treatment(Standard Care; SC) and brief advice and follow-up, nicotine patch, with the addition o...
What is the current status of trial NCT00551720?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 444 participants. The study started on 1999-01. Estimated completion is 2004-12.
What interventions are being tested in trial NCT00551720?
The interventions under investigation include: Standard Care (BEHAVIORAL), Motivational Enhancement (BEHAVIORAL).
Who is sponsoring clinical trial NCT00551720?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.